VERTEX PHARMACEUTICALS INC【VRTX】Balance sheet

Market cap

$119.1B

P/E ratio

	2010/12	2011/12	2012/12	2013/12	2014/12	2015/12	2016/12	2017/12	2018/12	2019/12	2020/12	2021/12	2022/12	2023/12	2024/12
Cash and cash equivalents	243	475	489	569	625	715	1,184	1,665	2,658	3,121	5,989	6,800	10,512	10,372	4,572
Marketable securities, current	788	494	832	896	762	328	251	847	1,036	699	671	730	275	849	1,546
Total cash & short-term investments	1,031	969	1,321	1,465	1,387	1,042	1,435	2,512	3,694	3,820	6,660	7,530	10,787	11,222	6,119
Accounts receivable, net	13	183	143	86	76	178	201	281	410	634	885	1,137	1,442	1,563	1,609
Inventories	-	112	30	14	31	57	78	112	124	168	281	353	461	739	1,205
Total current assets	1,057	1,331	1,590	1,589	1,547	1,407	1,832	2,649	3,843	4,823	8,133	9,561	13,235	14,144	9,596
Property, plant and equipment, net	72	133	434	697	716	698	698	789	812	-	-	-	-	-	-
Marketable securities, non-current	-	-	-	-	-	-	-	-	-	-	-	-	-	2,498	5,108
Total non-current assets	668	873	1,170	730	788	1,092	1,065	897	2,403	3,496	3,618	3,872	4,916	8,586	12,937
Total assets	1,725	2,204	2,759	2,319	2,335	2,499	2,897	3,546	6,246	8,318	11,752	13,433	18,151	22,730	22,533
Accounts payable	36	75	101	49	71	75	61	74	111	88	155	195	304	365	413
Total current liabilities	475	392	433	398	368	506	793	807	1,120	1,335	1,878	2,142	2,742	3,547	3,565
Total non-current liabilities	747	846	1,092	565	870	899	766	696	690	898	1,187	1,191	1,496	1,602	2,559
Total liabilities	1,221	1,239	1,525	963	1,238	1,405	1,559	1,504	1,811	2,233	3,065	3,333	4,238	5,150	6,124
Common stock and paid-in capital	2	2	2	2	2	2	2	3	3	3	3	3	3	3	3
Retained earnings	-3,444	-3,415	-3,522	-3,967	-4,705	-5,262	-5,374	-5,120	-2,989	-1,853	859	3,201	6,523	10,142	9,607
Stockholders' equity	504	928	1,196	1,356	1,096	1,094	1,338	2,042	4,435	6,085	8,687	10,100	13,913	17,580	16,410
Working capital	-